Bank of New York Mellon’s Merck MRK Stock Holding History
Bought
Maintained
Sold
Other funds holding MRK
Bank of New York Mellon's MRK Position: Q2 2026 in Review
Bank of New York Mellon reduced its Merck (MRK) stake by 2% in Q2 2026, selling an estimated $43.7M and leaving 18,340,173 shares worth $2.36B. The position accounts for 0.39% of the portfolio, ranked #44.
Bank of New York Mellon first reported a position in MRK in Q2 2013 and has held it in 53 quarters since. The position peaked at $3.54B in Q3 2016. 3,080 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Bank of New York Mellon held 18,340,173 shares of Merck worth $2.36B as of Q2 2026.
- Bank of New York Mellon sold 373,190 Merck shares in Q2 2026, an estimated $43.7M.
- Merck made up 0.39% of Bank of New York Mellon's portfolio in Q2 2026, its #44 holding.
- Bank of New York Mellon first reported a position in Merck in Q2 2013 and has held it in 53 quarters since.
- Bank of New York Mellon's Merck position peaked at $3.54B in Q3 2016.
- 3,080 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.